Loading...
XSHG600227
Market cap495mUSD
Jan 10, Last price  
2.16CNY
1D
-4.42%
1Q
12.50%
Jan 2017
-70.21%
Name

Guizhou Chitianhua Co Ltd

Chart & Performance

D1W1MN
XSHG:600227 chart
P/E
—
P/S
1.62
EPS
—
Div Yield, %
1.18%
Shrs. gr., 5y
-0.41%
Rev. gr., 5y
-1.57%
Revenues
2.25b
-10.79%
731,494,222874,234,153852,923,6021,113,692,8401,148,163,7431,112,171,8751,329,324,7031,960,950,0503,504,164,6324,149,879,8643,286,700,2842,761,478,1832,856,923,3461,692,959,3992,430,806,7582,026,286,2361,926,852,8912,181,369,7462,517,340,2572,245,779,037
Net income
-119m
105,614,607175,085,268170,627,164192,206,576165,878,425137,417,593125,298,46892,854,28435,290,23811,074,977020,248,315036,711,602197,329,127055,605,34200-119,274,849
CFO
308m
+57.45%
155,195,242339,377,301224,660,970258,217,509277,290,756303,459,04695,499,725383,970,770592,122,978183,510,247339,410,39738,264,931129,178,6270523,349,443140,093,494264,557,038276,666,953195,615,283307,992,942
Dividend
May 06, 20140.02 CNY/sh
Earnings
May 16, 2025

Profile

Guizhou Salvage Pharmaceutical Co.,Ltd. produces and sells urea and methanol in China. The company offers urea fertilizers under the Chi brand; methanol products; and ammonium sulfate, chlorine, and potassium sulfate fertilizers. It also produces and sells medicines, medical devices, and health products for diabetes, cardiovascular, skin disease, gynecology, respiratory tract, digestive system, endocrine, mental nerve, heart, kidney, blood system, circulatory system, and nervous system areas. The company was formerly known as Guizhou Chitianhua Co., Ltd. Guizhou Salvage Pharmaceutical Co.,Ltd. was founded in 1998 and is based in Guiyang, China.
URL
http://www.gzsjt.com/
IPO date
Feb 21, 2000
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
2,245,779
-10.79%
2,517,340
15.40%
Cost of revenue
2,331,795
2,587,929
Unusual Expense (Income)
NOPBT
(86,016)
(70,589)
NOPBT Margin
Operating Taxes
(21,954)
4,609
Tax Rate
NOPAT
(64,062)
(75,198)
Net income
(119,275)
 
Dividends
(42,886)
(20,060)
Dividend yield
0.96%
0.39%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
426,745
290,142
Long-term debt
494,590
409,083
Deferred revenue
31,436
23,414
Other long-term liabilities
1
Net debt
673,226
407,925
Cash flow
Cash from operating activities
307,993
195,615
CAPEX
(203,114)
Cash from investing activities
(224,936)
Cash from financing activities
225,319
FCF
142,324
(31,105)
Balance
Cash
231,438
94,557
Long term investments
16,670
196,743
Excess cash
135,819
165,433
Stockholders' equity
374,783
2,006,114
Invested Capital
3,488,607
3,350,277
ROIC
ROCE
EV
Common stock shares outstanding
1,694,245
1,693,134
Price
2.63
-13.20%
3.03
-20.05%
Market cap
4,455,864
-13.14%
5,130,197
-20.05%
EV
5,129,091
5,538,121
EBITDA
110,020
107,290
EV/EBITDA
46.62
51.62
Interest
44,447
20,031
Interest/NOPBT